Hiantis was founded in 2014 in Milano (Italy) to turn into products and services, ideas stemmed out of founders’ experiences and expertise in clinical practice and microbiological research.
2104: Establishment of the Company with the support of a public funding from ‘Italia Lavoro S.p.A’ (now ANPAL Servizi S.p.A.) through the Call ‘Manager to Work’.
2016: Licensing to an Italian Medium Pharmaceutical Company of a Patent that protects pharmaceutical formulations for the prevention and treatment of osteoporosis.
2018: Funding from the European Commission, within the Program Horizon 2020-SME Instrument-05-2016-2017 (Supporting innovative SMEs in the healthcare biotechnology sector), in partnership with Genefirst from Oxford (UK), of a Project for the development and clinical validation of in vitro diagnostic devices for the diagnosis of HPV cervical infection and the prevention of cervical cancer (https://cordis.europa.eu/project/id/806551/it).
2019: Participation to ATMA-EC Platform, set up by BBMRI.it (the Italian hub of Biobanking and Biomolecular Research Infrastructure), an Expert Centre to accelerate clinical research with focus on biomarker verification and validation (https://www.bbmri-eric.eu/services/expert-centre/).
2019: Opening of an Operational Site in Brescia (Italy) for the development and production of in-vitro diagnostic devices
2020: Funding from Regione Lombardia (Azione I.1.b.1.3 dell’Asse 1 del POR FESR 2014- 2020) as a ‘ Measure to support the development of collaborations for the identification of therapies and diagnostic, protection and analysis systems to counter the Coronavirus emergency and other viral emergencies of the future’, in partnership with the Universities of Milano and Milano-Bicocca, the ASSTs of Bergamo and Monza and the Companies Copan S.p.A. of Brescia and Lutech S.p.A of Milano.
2021: Acquisition of ISO 13845 Certificate from Bureau Veritas
2021: First CE Marking of an In-vitro diagnostic device (IVD). Screen KIT nCoV-2/QUANTICOR, For the diagnosis and quantification of coronavirus